ConferenceOsteoporosis International · September 19, 2014
Summary: To determine persistence with subcutaneous denosumab every 6 months in women being treated for osteoporosis, we conducted a single-arm prospective, observational study in the United States and Canada. Among 935 patients enrolled, 12-month persiste ...
Full textCite
ConferenceHealth and quality of life outcomes · January 1, 2013
The aim of this study is to examine the associations between health utility (HU), health-related quality of life (HRQoL), and patient characteristics in postmenopausal osteoporotic (PMO) women. Baseline data from a subsample of 1,245 participants of the Mu ...
Full textCite
ConferenceJ Manag Care Pharm · July 2006
OBJECTIVE: To define medication adherence and describe the limitations of various assessment methods, reasons for nonadherence to medications used to manage chronic illness, the impact of nonadherence to osteoporosis medications, and strategies for improvi ...
Full textLink to itemCite